InsiderTrades

Form 4 for TELA TELA Bio, Inc.

Accepted 2021-09-13 00:00:00 ET · period of report 2021-09-09 · accession 0000899243-21-035636 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
MI 2021-09-13 2021-09-09+ TELA EW Healthcare Partners Fund 2 GP, L.P. 10% P - Purchase $12.38 +27.5K 1.80M +2% +$340.8K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, par value $0.001 per share 2021-09-10 P A 14,436 $12.31 1,811,933 I See footnotes — — (F2) EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. (F1) Shares shown above were the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 5,321 shares and 5,673 shares of the amount shown above on September 9 and 10, respectively, and Fund 2-A purchased 7,766 shares and 8,763 shares of the amount shown above on September 9 and 10, respectively. Fund 2 now holds a total of 753,185 shares and Fund 2-A now holds a total of 1,058,748 shares of the Issuer.
2 Common Common Stock, par value $0.001 per share 2021-09-09 P A 13,087 $12.46 1,797,497 I See footnotes — — (F2) EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. (F1) Shares shown above were the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 5,321 shares and 5,673 shares of the amount shown above on September 9 and 10, respectively, and Fund 2-A purchased 7,766 shares and 8,763 shares of the amount shown above on September 9 and 10, respectively. Fund 2 now holds a total of 753,185 shares and Fund 2-A now holds a total of 1,058,748 shares of the Issuer.